Century Pharmaceuticals Limited is actively engaged in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and has a strong focus on biotechnology and contract research services. The company has established a Biotechnology Research Division that emphasizes drug discovery and the development of novel molecules, initiated in 2007. Their research includes significant advancements in stem cell therapy, which began in 2014, aiming to harness the potential of stem cells for treating various diseases, including heart disease, diabetes, and spinal cord injuries. The company adheres to Good Manufacturing Practices (GMP) and maintains rigorous quality control and assurance protocols to ensure the safety and efficacy of their products.

In addition to stem cell research, Century Pharmaceuticals is involved in recombinant DNA technology, which allows for the production of therapeutic proteins to treat conditions such as asthma and allergies. They are also developing targeted therapies for diseases mediated by specific signals and receptors, with preclinical evaluations already underway. The company is committed to innovation through collaborations with academic institutions and has signed multiple MOUs to enhance their research capabilities. Their product development efforts include bioactive compounds like calcitriol and serratiopeptidase, which are aimed at addressing various health conditions while minimizing side effects.

India

Century Pharmaceuticals Ltd is a privately held Pharmaceutical Company based out Vadodara, India. For more than 30 years, we have emerged as a respectable name in the industry. Our services include manufacturing APIs, facilities for contract manufacturing, Biotechnology research, API research, stability studies, and more. 

Century Pharmaceuticals Limited

Company Details